BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 6935909)

  • 1. Antepartal cardiotocography in the assessment of fetal outcome.
    Käär K
    Acta Obstet Gynecol Scand Suppl; 1980; 94():1-56. PubMed ID: 6935909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of high risk pregnancy.
    Anuman-Rajadhon Y; Pattanachak C; Manassakorn J
    J Med Assoc Thai; 1978 Oct; 61(10):576-85. PubMed ID: 712279
    [No Abstract]   [Full Text] [Related]  

  • 4. Daily antenatal cardiotocography in the management of high-risk pregnancies.
    Weiss DB; Pugh C; Simmons SC
    Int Surg; 1977 Sep; 62(9):470-5. PubMed ID: 908631
    [No Abstract]   [Full Text] [Related]  

  • 5. [Placental perfusion, endocrine parameters of pregnancy and cardiotocographic non-stress tests in cases of intrauterine retardation].
    Doszpod J; Török M; Prievara F; Csákány MG; Gáti I
    Zentralbl Gynakol; 1984; 106(21):1413-8. PubMed ID: 6516633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uses of oestriol as a monitoring tool.
    Goebelsmann U
    Clin Obstet Gynaecol; 1979 Aug; 6(2):223-44. PubMed ID: 498679
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monitoring of EPH-gestosis through the Gestosis Index and hormone determinations].
    Weber H
    Fortschr Med; 1977 Jul; 95(25):1630-34. PubMed ID: 69597
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of pregnancy at risk: evaluation of fetal movements, determination of total plasma estriol and placental lactogen hormone in relation to fetal heart rhythm].
    Mbanzulu PN; Leng JJ; Commenges D; Salamon R
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):779-84. PubMed ID: 3794214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of fetal outcome by urinary estriol, maternal serum placental lactogen, and alpha-fetoprotein in diabetes and hepatosis of pregnancy.
    Garoff L
    Obstet Gynecol; 1976 Dec; 48(6):659-66. PubMed ID: 63107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of fetuses in the late pregnancy by serial determinations of serum human placental lactogen levels].
    Kaibara M; Marumoto Y; Taniguchi I; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1724-8. PubMed ID: 7175278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on the relation among oxytocin challenge test, maternal serum estriol level and placental change (author's transl)].
    Sawazumi K; Tonari M; Sakai K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):589-93. PubMed ID: 7086240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal stress and nonstress tests: an analysis and comparison of their ability to identify fetal outcome.
    Pratt D; Diamond F; Yen H; Bieniarz J; Burd L
    Obstet Gynecol; 1979 Oct; 54(4):419-23. PubMed ID: 492619
    [No Abstract]   [Full Text] [Related]  

  • 13. The hormonal assessment of fetal and placental function.
    Chard T
    Clin Obstet Gynaecol; 1974 Apr; 1(1):85-102. PubMed ID: 4471499
    [No Abstract]   [Full Text] [Related]  

  • 14. [The hormonal assessment of fetal status: total estriol and chorionic somatomammotropin].
    Espinosa de los Monteros A; Patiño Lemus R; Avila Rosas H; Karchmer S
    Ginecol Obstet Mex; 1988 Oct; 56():268-72. PubMed ID: 3154253
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of placental enzymes, endocrinologic parameters of pregnancy and placental perfusion in cases of intrauterine growth retardation].
    Doszpod J; Török M; Csákány MG; Prievara F; Gátai K; Tanka D; Gáti I
    Zentralbl Gynakol; 1986; 108(2):84-9. PubMed ID: 3953182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Placental (HPL, HSAP, CAP) and fetal (estriol in urine and blood) parameters in high risk pregnancies].
    Battaglia GB; Morresi G; Coronella L; Messeri G; Valenza T
    Quad Sclavo Diagn; 1977 Dec; 13(4):434-48. PubMed ID: 351694
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxytocin challenge test in high-risk pregnancy.
    Farahani G; Vasudeva K; Petrie R; Fenton AN
    Obstet Gynecol; 1976 Feb; 47(2):159-68. PubMed ID: 1250537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human placental lactogen.
    Letchworth AT
    Contrib Gynecol Obstet; 1976; 2():114-42. PubMed ID: 802077
    [No Abstract]   [Full Text] [Related]  

  • 19. [Special investigations in intrauterine growth retardation and threatened fetal death].
    Skjaeraasen JS
    Tidsskr Nor Laegeforen; 1972 Oct; 92(29):1922-3. PubMed ID: 4635665
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxytocin challenge test in monitoring high-risk pregnancies.
    Cooper JM; Soffronoff EC; Bolognese RJ
    Obstet Gynecol; 1975 Jan; 45(1):27-33. PubMed ID: 1110815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.